Immune checkpoint inhibitor therapy for cancer patients infected with HIV: A systematic review.
Ling LuoYan XuTai-Sheng LiPublished in: Asia-Pacific journal of clinical oncology (2020)
The review shows that ICI appears to be feasible in this specific population. Efficacy and tolerability seemed to be comparable with that of general population with advanced cancers.